| scholarly article | Q13442814 |
| P2093 | author name string | E Fikrig | |
| M Akkoyunlu | |||
| P2860 | cites work | Multiple defects of immune cell function in mice with disrupted interferon-gamma genes | Q28267397 |
| Functional diversity of helper T lymphocytes | Q29619415 | ||
| Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. | Q32060639 | ||
| Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? | Q33491610 | ||
| Clinical and laboratory characteristics of human granulocytic ehrlichiosis | Q33495484 | ||
| Human granulocytic ehrlichiosis in Connecticut: report of a fatal case | Q33495868 | ||
| Human granulocytic ehrlichiosis: a case series from a medical center in New York State | Q33498031 | ||
| Human ehrlichioses: newly recognized infections transmitted by ticks | Q33501954 | ||
| Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut | Q33503644 | ||
| Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. | Q33685558 | ||
| Characterization of monoclonal antibodies to the 44-kilodalton major outer membrane protein of the human granulocytic ehrlichiosis agent. | Q33687967 | ||
| Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice | Q36362141 | ||
| A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. | Q36364671 | ||
| Human disease in Europe caused by a granulocytic Ehrlichia species. | Q36544664 | ||
| Immunization against the agent of human granulocytic ehrlichiosis in a murine model | Q37376171 | ||
| Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle | Q37578634 | ||
| Constructing polycompetitor cDNAs for quantitative PCR. | Q38315767 | ||
| Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups | Q40015097 | ||
| Human granulocytic ehrlichiosis in a renal transplant patient: case report and review of the literature | Q40645193 | ||
| Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence | Q40670699 | ||
| Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. | Q41282648 | ||
| Inhibition of Viral Replication by Interferon-γ-Induced Nitric Oxide Synthase | Q41528238 | ||
| Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin | Q43683017 | ||
| IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages | Q44173170 | ||
| Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes | Q44378254 | ||
| Serological evidence of human granulocytic ehrlichiosis in Norway | Q45269151 | ||
| Granulocytic ehrlichiosis in the laboratory mouse | Q46223139 | ||
| Serological evidence of human granulocytic ehrlichiosis in Switzerland | Q47841370 | ||
| Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii | Q47901722 | ||
| Human ehrlichiosis in a liver transplant recipient. | Q52535873 | ||
| Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. | Q52536788 | ||
| LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile. | Q52906796 | ||
| IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis | Q54285337 | ||
| In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha | Q57339973 | ||
| Cytokine Interaction and Immune Responses during Schistosoma mansoni Infection | Q58312832 | ||
| IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi | Q58843169 | ||
| Human granulocytic ehrlichiosis in New York | Q64133215 | ||
| Resistance to Leishmania major induced by tolerance to a single antigen | Q71595277 | ||
| Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages | Q71608575 | ||
| Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis | Q73458982 | ||
| Demyelinating polyneuropathy associated with human granulocytic ehrlichiosis | Q77595519 | ||
| Fatal pancarditis associated with human granulocytic Ehrlichiosis in a 44-year-old man | Q77735486 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1827-1833 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia | |
| P478 | volume | 68 |
| Q40119336 | ADAM10 and Notch1 on murine dendritic cells control the development of type 2 immunity and IgE production. |
| Q37973905 | Adaptive immunity to Anaplasma pathogens and immune dysregulation: implications for bacterial persistence |
| Q34323818 | Anaplasma phagocytophilum dihydrolipoamide dehydrogenase 1 affects host-derived immunopathology during microbial colonization |
| Q34390832 | Anaplasma phagocytophilum, interferon gamma production and Stat1 signaling |
| Q27006742 | Anaplasma phagocytophilum: deceptively simple or simply deceptive? |
| Q33552798 | CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains |
| Q38872601 | Chromatin-bound bacterial effector ankyrin A recruits histone deacetylase 1 and modifies host gene expression. |
| Q34007395 | Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis |
| Q47562779 | CpG ODN 2006 and IL-12 are comparable for priming Th1 lymphocyte and IgG responses in cattle immunized with a rickettsial outer membrane protein in alum. |
| Q33945418 | Cytokine gene expression by peripheral blood leukocytes in horses experimentally infected with Anaplasma phagocytophila |
| Q33396935 | Dexamethasone-induced cytokine changes associated with diminished disease severity in horses infected with Anaplasma phagocytophilum |
| Q57138947 | Differential Susceptibility of Male Versus Female Laboratory Mice to Infection |
| Q35913376 | Differential innate immune cell activation and proinflammatory response in Anaplasma phagocytophilum infection. |
| Q34194836 | Early transcriptional response of human neutrophils to Anaplasma phagocytophilum infection |
| Q34111734 | Effects of Anaplasma phagocytophilum on host cell ferritin mRNA and protein levels |
| Q78643603 | Elimination of erythrocytes from blood prior to DNA extraction improves the sensitivity of anaplasma phagocytophila PCR |
| Q33471440 | Epigenetic silencing of host cell defense genes enhances intracellular survival of the rickettsial pathogen Anaplasma phagocytophilum |
| Q34665901 | Epitope-based vaccines with the Anaplasma marginale MSP1a functional motif induce a balanced humoral and cellular immune response in mice |
| Q53063435 | Evaluation of humoral and cellular immune response of BALB/c mice immunized with a recombinant fragment of MSP1a from Anaplasma marginale using carbon nanotubes as a carrier molecule. |
| Q46274662 | Evidence for modulated immune response to Anaplasma phagocytophila sensu lato in cats with FIV-induced immunosuppression |
| Q34041825 | Experimental infection of white-tailed deer with Anaplasma phagocytophilum, etiologic agent of human granulocytic anaplasmosis |
| Q34008948 | Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis |
| Q33344202 | Human granulocytic ehrlichiosis in a renal allograft recipient: review of the clinical spectrum of disease in solid organ transplant patients |
| Q58261558 | IgG responses to salivary gland extract of Ixodes ricinus ticks vary inversely with resistance in naturally exposed sheep |
| Q35842136 | Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis |
| Q42947543 | Impairment of gamma interferon signaling in human neutrophils infected with Anaplasma phagocytophilum. |
| Q33385187 | Infection with Anaplasma phagocytophilum induces multilineage alterations in hematopoietic progenitor cells and peripheral blood cells |
| Q38734461 | Influence of Genetic Background on Hematologic and Histopathologic Alterations during Acute Granulocytic Anaplasmosis in 129/SvEv and C57BL/6J Mice Lacking Type I and Type II Interferon Signaling |
| Q34720459 | Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury |
| Q33896496 | Interferon-γ-dependent control of Anaplasma phagocytophilum by murine neutrophil granulocytes |
| Q35553339 | Invasion and survival strategies ofAnaplasma phagocytophilum |
| Q43777175 | Kinetics of CD11b/CD18 up-regulation during infection with the agent of human granulocytic ehrlichiosis in mice |
| Q34132762 | Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a. |
| Q35090150 | Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum |
| Q37594405 | Nanoparticle-Based Delivery of Anaplasma marginale Membrane Proteins; VirB9-1 and VirB10 Produced in the Pichia pastoris Expression System |
| Q36488241 | Receptor interacting protein-2 contributes to host defense against Anaplasma phagocytophilum infection |
| Q34662527 | Resolution of chronic hepatitis C following parasitosis |
| Q34476289 | Stat1 negatively regulates immune-mediated injury with Anaplasma phagocytophilum infection |
| Q38352791 | Structurally distinct requirements for binding of P-selectin glycoprotein ligand-1 and sialyl Lewis x to Anaplasma phagocytophilum and P-selectin |
| Q35667197 | The biological basis of severe outcomes in Anaplasma phagocytophilum infection |
| Q23922268 | The determination of draining lymph node cell cytokine mRNA levels in BALB/c mice following dermal sodium lauryl sulfate, dinitrofluorobenzene, and toluene diisocyanate exposure |
| Q82755268 | The elimination of Anaplasma phagocytophilum requires CD4+ T cells, but is independent of Th1 cytokines and a wide spectrum of effector mechanisms |
| Q33386538 | The natural history of Anaplasma phagocytophilum |
| Q27008840 | The role of CD8 T lymphocytes in rickettsial infections |
| Q60044062 | VirB10 vaccination for protection against Anaplasma phagocytophilum |
| Q36422142 | c-Jun NH2-terminal kinase 2 inhibits gamma interferon production during Anaplasma phagocytophilum infection |
Search more.